257 related articles for article (PubMed ID: 9694549)
1. Direct vascular effects of HMG-CoA reductase inhibitors.
Bellosta S; Bernini F; Ferri N; Quarato P; Canavesi M; Arnaboldi L; Fumagalli R; Paoletti R; Corsini A
Atherosclerosis; 1998 Apr; 137 Suppl():S101-9. PubMed ID: 9694549
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
3. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Corsini A; Bernini F; Quarato P; Donetti E; Bellosta S; Fumagalli R; Paoletti R; Soma VM
Cardiology; 1996; 87(6):458-68. PubMed ID: 8904671
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R
Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791
[TBL] [Abstract][Full Text] [Related]
5. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
[TBL] [Abstract][Full Text] [Related]
6. Direct effects of statins on the vascular wall.
Corsini A; Pazzucconi F; Arnaboldi L; Pfister P; Fumagalli R; Paoletti R; Sirtori CR
J Cardiovasc Pharmacol; 1998 May; 31(5):773-8. PubMed ID: 9593078
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacology of the statins: the evidence of a direct antiatherosclerotic action].
Raiteri M; Arnaboldi L; Quarato P; Paoletti R; Fumagalli R; Corsini A
Ann Ital Med Int; 1995 Oct; 10 Suppl():35S-42S. PubMed ID: 8562263
[TBL] [Abstract][Full Text] [Related]
8. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
Koh KK
Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
[TBL] [Abstract][Full Text] [Related]
9. Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes.
Corsini A; Arnaboldi L; Raiteri M; Quarato P; Faggiotto A; Paoletti R; Fumagalli R
Pharmacol Res; 1996 Jan; 33(1):55-61. PubMed ID: 8817647
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress.
Yasunari K; Maeda K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):937-42. PubMed ID: 11397700
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
12. New insights into the pharmacodynamic and pharmacokinetic properties of statins.
Corsini A; Bellosta S; Baetta R; Fumagalli R; Paoletti R; Bernini F
Pharmacol Ther; 1999 Dec; 84(3):413-28. PubMed ID: 10665838
[TBL] [Abstract][Full Text] [Related]
13. Statins effect on smooth muscle cell proliferation.
Bellosta S; Arnaboldi L; Gerosa L; Canavesi M; Parente R; Baetta R; Paoletti R; Corsini A
Semin Vasc Med; 2004 Nov; 4(4):347-56. PubMed ID: 15861311
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
Sakai M; Kobori S; Matsumura T; Biwa T; Sato Y; Takemura T; Hakamata H; Horiuchi S; Shichiri M
Atherosclerosis; 1997 Aug; 133(1):51-9. PubMed ID: 9258407
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
17. Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration.
Komukai M; Wajima YS; Tashiro J; Shinomiya M; Saito Y; Morisaki N
Scand J Clin Lab Invest; 1999 May; 59(3):159-66. PubMed ID: 10400160
[TBL] [Abstract][Full Text] [Related]
18. Direct effects of statins on cells primarily involved in atherosclerosis.
Chen H; Ikeda U; Shimpo M; Shimada K
Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitors reduce acetyl LDL endocytosis in mouse peritoneal macrophages.
Bernini F; Scurati N; Bonfadini G; Fumagalli R
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1352-8. PubMed ID: 7670949
[TBL] [Abstract][Full Text] [Related]
20. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]